HFNC Vs LFNC in Patients with AF Undergoing RFCA Under Deep Sedation.
Reason given: Due to changes in logistics (indications Rf and attendance PFA), it has not been feasible to include the required number of participants in this study
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Trial details
- Who runs it
- Maastricht University Medical Center
- Trial code
- NCT04842253
- Record updated
- 20 February 2025
- Original description
Oxygen supplementation through high flow nasal cannula (HFNC) may reduce the incidence of desaturation and hypoxemia during deep sedation at radiofrequency catheter ablation (RFCA procedures).This study is designed to test the hypothesis that the incidence of hypoxemia and desaturation in patients with atrial fibrillation undergoing RFCA under deep sedation, is less when using HFNC as compared to use of standard low flow nasal cannula (LFNC).Read full original descriptionShow less
High Flow Nasal Cannula (HFNC) Versus Standard Low Flow Nasal Cannula (LFNC) in Patients with Atrial Fibrillation Undergoing Radiofrequency Catheter Ablation (RFCA) Under Deep Desaturation.
Oxygen supplementation through high flow nasal cannula (HFNC) may reduce the incidence of desaturation and hypoxemia during deep sedation at radiofrequency catheter ablation (RFCA procedures).This study is designed to test the hypothesis that the incidence of hypoxemia and desaturation in patients with atrial fibrillation undergoing RFCA under deep sedation, is less when using HFNC as compared to use of standard low flow nasal cannula (LFNC).
Inclusion: Adults undergoing an elective RFCA for atrial fibrillation in the Maastricht UMC Cardiac Catheter Labs under deep sedation administered by a clinician anesthesiology.
Exclusion: Recent upper airway surgery; Diagnosed Sleep Apnoea Syndrome (SAS); Chronic Pulmonary Obstructive Disease (COPD) gold IV and COPD gold III with frequent or recent exacerbation; Diagnosed pulmonary or cardiac condition requiring chronic oxygen therapy; Active nose bleeding; Age under 18 years; Body Mass Index (BMI) > 32 kg/m²; Complete nasal obstruction; Untreated pneumothorax (pre- existing); Recent base of skull fracture; Expected difficult airway.